Scinai Immunotherapeutics Restructures Debt, Boosts Equity
PremiumCompany AnnouncementsScinai Immunotherapeutics Restructures Debt, Boosts Equity
3M ago
Scinai Secures $2M Investment Boost
Premium
Company Announcements
Scinai Secures $2M Investment Boost
3M ago
Scinai enters $2M investment commitment agreement with RK Stone
Premium
The Fly
Scinai enters $2M investment commitment agreement with RK Stone
3M ago
Scinai Immunotherapeutics’ IL-17 nanoAb receives positive regulatory feedback
PremiumThe FlyScinai Immunotherapeutics’ IL-17 nanoAb receives positive regulatory feedback
4M ago
Scinai’s Psoriasis Treatment Shows Promising Results
Premium
Company Announcements
Scinai’s Psoriasis Treatment Shows Promising Results
4M ago
Scinai Immunotherapeutics Advances with Promising Q1 Results
Premium
Company Announcements
Scinai Immunotherapeutics Advances with Promising Q1 Results
4M ago
Scinai Immunotherapeutics receives updated LOI from EIB
PremiumThe FlyScinai Immunotherapeutics receives updated LOI from EIB
4M ago
Scinai Immunotherapeutics reports Q1 EPS ($0.001c) vs ($0.003) last year
Premium
The Fly
Scinai Immunotherapeutics reports Q1 EPS ($0.001c) vs ($0.003) last year
4M ago
Scinai Immunotherapeutics: Innovating Nanobody Therapeutics
Premium
Company Announcements
Scinai Immunotherapeutics: Innovating Nanobody Therapeutics
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100